OTG response to the Shape of Training Review
The Ophthalmic Trainees’ Group has issued its response to the Shape of Training review. OTG_response_to_the_Shape_of_Training_review
Quality Standards for Services for Patients with Learning Disabilities
There are numerous personal accounts nationwide of ways in which ophthalmologists have been able to enhance the quality of life of people with learning disability. The impact of an intervention to improve sight should not be underestimated. In 2011 The Royal College of Ophthalmologists, with the support of SeeAbility, VISION 2020 UK and the RNIB,
Safeguarding children and young people: roles and competences for health care staff
All health staff must have the competences to recognise child maltreatment and to take effective action as appropriate to their role. They must also clearly understand their responsibilities, and should be supported by their employing organisation to fulfil their duties. Chief Executive officers and independent contractors such as GPs, in particular have a responsibility to
Response to Mr Michael Clarke’s personal views ‘NHS sight tests include unevaluated screening examinations’
College Statement The Royal College of Ophthalmologists Issues a Response to Mr Michael Clarke’s personal views expressed in his paper titled ‘NHS sight tests include unevaluated screening examinations that lead to waste’. In a personal view recently published on bmj.com, a leading eye doctor says that opticians are making too many referrals to doctors. Mr
Choice of anti VEGF agents for wet AMD treatments
College Statement Ophthalmologists have a choice of two anti-VEGF agents for the treatment of wet AMD, following NICE guidance on Ranibizumab (TA155) and Aflibercept (TA294). Photodynamic therapy is also licensed and approved and still has a role in a small subset of patients. An anti-VEGF agent is generally used for the treatment of wet AMD